| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030637 |
| Receipt No. | R000034982 |
| Official scientific title of the study | Study on influence on peripheral blood flow and cold by intake of fish oil |
| Date of disclosure of the study information | 2018/01/10 |
| Last modified on | 2018/12/26 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study on influence on peripheral blood flow and cold by intake of fish oil | |
| Title of the study (Brief title) | Study on influence of cold | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Study on influence on peripheral blood flow and cold by intake of fish oil |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in body temperature and peripheral blood flow before ingestion and after ingestion period |
| Key secondary outcomes | Subjective symptom questionnaire on cold (VAS) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Test food: intake of fish oil
2.4g/day, 8 weeks |
|
| Interventions/Control_2 | Placebo food: intake of corn oil
2.4g/day, 8 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Japanese females aged 20 to 49 years old at the time of acquiring consent
2) Persons who are sensitive to cold |
|||
| Key exclusion criteria | During pregnancy or possibly pregnant, and those who are breastfeeding
Persons who are likely to have allergic symptoms due to the tested component Persons participating in other clinical trials Persons who have a history of serious liver disorder, kidney disorder, heart disease Persons who have a history of gastrointestinal disease Persons who are taking medicine for digestive system diseases Persons who have a long history of medical illness Smoker Persons who have a history of frostbite or who currently suffer Persons who eat blue fish (maize, mackerel, sardine, saury, etc) for more than 4 days a week Persons who are taking medicines (such as pharmaceuticals based on ethyl icosapentate) or supplements (EPA, DHA, hesperidin, capsaicin, ginger extract, Hiichatsu etc.) that have an influence on the test results Persons who have consciousness of menopausal disorder Alcoholic drinkers (eg everyday, 3 or more beer bottles) Persons with menstrual irregularity Persons with irregular lifestyle (timing of meals is not fixed, insufficient sleep etc.) Persons with irregular shift work and late night work Persons who are suffering from specific diseases and who are visiting hospital, medication or treatment Persons who exercise for over an hour every day |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Koikeda |
| Organization | Shiba Palace Clinic |
| Division name | Chair |
| Address | 6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan |
| TEL | 03-5408-1590 |
| jimukyoku@mail.souken-r.com | |
| Public contact | |
| Name of contact person | Ko MASUDA |
| Organization | SOUKEN Co., Ltd |
| Division name | Management Division |
| Address | 3F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan |
| TEL | 03-5408-1555 |
| Homepage URL | |
| k_masuda@mail.souken-r.com | |
| Sponsor | |
| Institute | Shiba Palace Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nippon Suisan Kaisha, Ltd., |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034982 |